Last month, the Third Circuit issued another appellate opinion in the long-gestating In re Fosamax litigation (3d Cir Sept. 20, 2024, – F. 4th, 2024 WL 4247311). The litigation, now well into its second decade, involves...more
Over the past decade, mass tort litigation involving de minimis levels of impurities has skyrocketed. One need only turn on the evening news to see advertisements for litigation related to allegedly carcinogenic or...more